CAMPHOR, MENTHOL

CAMPHOR, MENTHOL was reported 822 times

CAMPHOR, MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE STIMULATION ISSUE 1 0.0400
1 SECOND DEGREE CHEMICAL BURN OF SKIN 2 0.0333
2 BURNS FOURTH DEGREE 1 0.0323
3 BLADDER ULCER 1 0.0244
4 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
5 CHEMICAL INJURY 18 0.0220
6 BURN INFECTION 3 0.0147
7 APPLICATION SITE BURN 57 0.0116
8 CHEMICAL BURN 13 0.0113
9 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 1 0.0111
10 BURNS SECOND DEGREE 19 0.0108
11 BURNS THIRD DEGREE 9 0.0085
12 ADMINISTRATION SITE RASH 1 0.0078
13 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
14 BURNS FIRST DEGREE 2 0.0070
15 BACTERIAL ABDOMINAL INFECTION 1 0.0068
16 FROSTBITE 2 0.0067
17 ORCHIDECTOMY 1 0.0062
18 ADULT FAILURE TO THRIVE 1 0.0047
19 APPLICATION SITE HYPOAESTHESIA 1 0.0043
20 NIPPLE SWELLING 1 0.0040
21 ANTICOAGULANT THERAPY 1 0.0035
22 WHITE BLOOD CELL COUNT 1 0.0034
23 DEVICE MAINTENANCE ISSUE 2 0.0034
24 APPLICATION SITE VESICLES 22 0.0034
25 THERMAL BURN 22 0.0031
26 INFUSION SITE INFLAMMATION 2 0.0028
27 APPLICATION SITE PUSTULES 1 0.0027
28 VASCULAR INSUFFICIENCY 1 0.0026
29 PRODUCT LABEL ON WRONG PRODUCT 1 0.0025
30 APPLICATION SITE SCAR 3 0.0024
31 ALVEOLAR OSTEITIS 1 0.0024
32 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
33 GENITAL BURNING SENSATION 2 0.0023
34 OESOPHAGEAL INFECTION 1 0.0022
35 ALLERGY TO PLANTS 1 0.0022
36 CHONDROLYSIS 1 0.0021
37 APPLICATION SITE BRUISE 2 0.0021
38 APPLICATION SITE INFECTION 1 0.0020
39 KELOID SCAR 1 0.0019
40 INFUSION SITE DISCOMFORT 2 0.0019
41 POSTNASAL DRIP 1 0.0018
42 PRODUCT CLOSURE ISSUE 1 0.0018
43 INTRACRANIAL HAEMATOMA 1 0.0018
44 MEDICAL DEVICE SITE PAIN 1 0.0018
45 ADMINISTRATION SITE PAIN 2 0.0017
46 APPLICATION SITE PAIN 38 0.0017
47 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
48 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
49 BLOOD BILIRUBIN DECREASED 1 0.0016
50 INTESTINAL FUNCTIONAL DISORDER 1 0.0016
51 CHEMICAL BURN OF SKIN 4 0.0016
52 INFUSION SITE IRRITATION 2 0.0016
53 GINGIVAL DISCOMFORT 1 0.0015
54 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
55 SKIN DEPIGMENTATION 2 0.0015
56 ARTHROSCOPY 1 0.0015
57 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
58 ESCHAR 1 0.0014
59 LIMB CRUSHING INJURY 1 0.0013
60 NEGATIVISM 1 0.0013
61 INFUSION SITE PRURITUS 4 0.0013
62 INCISION SITE HAEMORRHAGE 1 0.0012
63 APPLICATION SITE DISCOLOURATION 5 0.0012
64 INFUSION SITE HAEMORRHAGE 4 0.0012
65 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
66 INFUSION SITE OEDEMA 1 0.0012
67 NASAL OEDEMA 2 0.0011
68 HEART TRANSPLANT 1 0.0011
69 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
70 BONE CONTUSION 1 0.0011
71 SKIN GRAFT 1 0.0011
72 PROSTATE INFECTION 1 0.0010
73 HYPERVIGILANCE 1 0.0010
74 WOUND SECRETION 4 0.0010
75 DUST ALLERGY 1 0.0010
76 OROPHARYNGEAL SWELLING 1 0.0010
77 APPLICATION SITE EXFOLIATION 4 0.0010
78 APPLICATION SITE ERYTHEMA 24 0.0009
79 BACTERIAL TEST POSITIVE 2 0.0009
80 NO ADVERSE EVENT 161 0.0009
81 BLOODY DISCHARGE 1 0.0009
82 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
83 INFUSION SITE WARMTH 1 0.0008
84 POST-ACUTE COVID-19 SYNDROME 1 0.0008
85 APPLICATION SITE SWELLING 4 0.0008
86 APPLICATION SITE WARMTH 1 0.0008
87 INFUSION SITE PAIN 10 0.0008
88 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
89 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
90 LIP EXFOLIATION 1 0.0008
91 OFF LABEL USE OF DEVICE 1 0.0007
92 CHONDROPATHY 2 0.0007
93 RHONCHI 1 0.0007
94 APPLICATION SITE INFLAMMATION 1 0.0007
95 INFUSION SITE ERYTHEMA 6 0.0007
96 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13 0.0007
97 SCAB 8 0.0007
98 SCAR 12 0.0007
99 INFUSION SITE INDURATION 1 0.0007
100 HYPOSMIA 1 0.0007
101 ORAL MUCOSAL ERUPTION 1 0.0007
102 INFUSION SITE SWELLING 4 0.0006
103 CYSTITIS INTERSTITIAL 1 0.0006
104 HYPERAESTHESIA 5 0.0006
105 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
106 SERUM FERRITIN DECREASED 1 0.0006
107 DRUG SCREEN NEGATIVE 1 0.0006
108 SKIN HYPOPIGMENTATION 1 0.0006
109 SCHIZOAFFECTIVE DISORDER 1 0.0006
110 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
111 DEVICE ALARM ISSUE 1 0.0006
112 BLISTER 30 0.0005
113 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
114 BLOOD IRON INCREASED 1 0.0005
115 STENOSIS 1 0.0005
116 TRAUMATIC HAEMORRHAGE 1 0.0005
117 JAUNDICE NEONATAL 1 0.0005
118 PANCREATIC CYST 1 0.0005
119 HYPOGEUSIA 1 0.0005
120 MULTI-ORGAN DISORDER 1 0.0005
121 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
122 PRODUCT ODOUR ABNORMAL 5 0.0005
123 URINARY BLADDER HAEMORRHAGE 1 0.0005
124 SLEEP DEFICIT 1 0.0005
125 APPLICATION SITE SCAB 1 0.0005
126 BURNING SENSATION 32 0.0005
127 LIMB MASS 1 0.0005
128 RHEUMATIC FEVER 2 0.0004
129 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
130 INFECTIOUS MONONUCLEOSIS 1 0.0004
131 URINARY TRACT DISORDER 2 0.0004
132 INFUSION SITE INFECTION 1 0.0004
133 NECK SURGERY 1 0.0004
134 PATELLA FRACTURE 1 0.0004
135 APPLICATION SITE REACTION 3 0.0004
136 SLOW SPEECH 1 0.0004
137 CARTILAGE INJURY 1 0.0004
138 DEVICE INFUSION ISSUE 1 0.0004
139 HYPERPARATHYROIDISM SECONDARY 1 0.0004
140 HAEMORRHAGE URINARY TRACT 1 0.0004
141 RADICULOPATHY 1 0.0004
142 SKIN BURNING SENSATION 27 0.0004
143 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
144 BREAST SWELLING 1 0.0004
145 APPLICATION SITE HAEMORRHAGE 1 0.0004
146 DRUG SCREEN FALSE POSITIVE 1 0.0004
147 NERVE INJURY 4 0.0004
148 DRUG TOLERANCE DECREASED 1 0.0004
149 NEUTROPHIL COUNT ABNORMAL 1 0.0004
150 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
151 DEVICE POWER SOURCE ISSUE 1 0.0003
152 PULMONARY PAIN 1 0.0003
153 LUMBAR SPINAL STENOSIS 1 0.0003
154 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
155 INFUSION SITE REACTION 1 0.0003
156 MYOSITIS 3 0.0003
157 BLOOD BLISTER 1 0.0003
158 NON-CARDIAC CHEST PAIN 1 0.0003
159 PROSTATE CANCER METASTATIC 1 0.0003
160 TERMINAL STATE 2 0.0003
161 WRONG PRODUCT ADMINISTERED 2 0.0003
162 APPLICATION SITE DRYNESS 1 0.0003
163 JOINT EFFUSION 2 0.0003
164 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
165 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
166 DEVICE OCCLUSION 4 0.0003
167 LUNG TRANSPLANT 1 0.0003
168 GLOSSITIS 1 0.0003
169 FRUSTRATION 1 0.0003
170 BLOOD PHOSPHORUS DECREASED 1 0.0003
171 RECTAL DISCHARGE 1 0.0003
172 WOUND HAEMORRHAGE 1 0.0003
173 PARANASAL SINUS HYPERSECRETION 1 0.0003
174 FAECES HARD 1 0.0003
175 SKIN ODOUR ABNORMAL 1 0.0003
176 ACCIDENT 3 0.0003
177 MUSCLE HAEMORRHAGE 1 0.0002
178 ENURESIS 1 0.0002
179 FRUSTRATION TOLERANCE DECREASED 2 0.0002
180 LEG AMPUTATION 1 0.0002
181 APPLICATION SITE IRRITATION 3 0.0002
182 POOR PERIPHERAL CIRCULATION 1 0.0002
183 INTERVERTEBRAL DISC DISORDER 1 0.0002
184 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
185 MUSCLE STRAIN 2 0.0002
186 IMMOBILE 1 0.0002
187 HAEMORRHAGIC ANAEMIA 1 0.0002
188 GINGIVAL SWELLING 1 0.0002
189 WHEELCHAIR USER 1 0.0002
190 IRON DEFICIENCY 1 0.0002
191 SUSPECTED OFF LABEL USE 1 0.0002
192 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
193 SKIN DISCOLOURATION 10 0.0002
194 NEPHROPATHY 2 0.0002
195 SKIN ABRASION 1 0.0002
196 EXPIRED PRODUCT ADMINISTERED 7 0.0002
197 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
198 THERAPY CHANGE 2 0.0002
199 HYPERVOLAEMIA 1 0.0002
200 EXPIRED DRUG ADMINISTERED 1 0.0002
201 DERMATITIS EXFOLIATIVE 1 0.0002
202 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
203 PATHOLOGICAL FRACTURE 1 0.0002
204 NECK PAIN 11 0.0002
205 PRODUCT ADHESION ISSUE 7 0.0002
206 VARICOSE VEIN 1 0.0002
207 FAILURE TO THRIVE 1 0.0002
208 COMPRESSION FRACTURE 1 0.0002
209 PAIN OF SKIN 5 0.0002
210 GINGIVITIS 1 0.0002
211 BACK INJURY 2 0.0002
212 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
213 TOOTH FRACTURE 2 0.0002
214 HYPERKERATOSIS 1 0.0002
215 STREPTOCOCCAL INFECTION 1 0.0002
216 SKIN EXFOLIATION 15 0.0002
217 APPLICATION SITE PRURITUS 4 0.0002
218 PERONEAL NERVE PALSY 1 0.0002
219 VENTRICULAR SEPTAL DEFECT 1 0.0002
220 NEOPLASM 2 0.0002
221 ENTEROCOLITIS 1 0.0002
222 SKIN WARM 1 0.0002
223 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
224 URINE ODOUR ABNORMAL 1 0.0002
225 DRUG INEFFECTIVE 223 0.0002
226 PLATELET COUNT ABNORMAL 1 0.0002
227 DERMATITIS ACNEIFORM 1 0.0002
228 VULVOVAGINAL BURNING SENSATION 1 0.0002
229 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
230 LIMB DISCOMFORT 5 0.0002
231 SCOLIOSIS 1 0.0002
232 POISONING 2 0.0002
233 MULTIPLE INJURIES 1 0.0002
234 TENDON DISORDER 1 0.0002
235 SINUS DISORDER 3 0.0002
236 QUALITY OF LIFE DECREASED 2 0.0001
237 PRODUCT LABEL ISSUE 1 0.0001
238 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
239 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
240 APPLICATION SITE RASH 2 0.0001
241 METASTASIS 1 0.0001
242 PANIC REACTION 1 0.0001
243 INJECTION SITE HAEMATOMA 2 0.0001
244 ORAL DISORDER 1 0.0001
245 BLINDNESS TRANSIENT 1 0.0001
246 SENSITIVE SKIN 1 0.0001
247 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
248 MUSCULOSKELETAL PAIN 7 0.0001
249 GENERAL SYMPTOM 1 0.0001
250 TENDON PAIN 1 0.0001
251 SKIN IRRITATION 6 0.0001
252 INSURANCE ISSUE 2 0.0001
253 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
254 PHARYNGEAL OEDEMA 2 0.0001
255 ATRIOVENTRICULAR BLOCK 1 0.0001
256 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
257 THERAPY PARTIAL RESPONDER 2 0.0001
258 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
259 NASAL DISCOMFORT 1 0.0001
260 RENAL CYST 1 0.0001
261 MOVEMENT DISORDER 4 0.0001
262 MUSCLE DISORDER 1 0.0001
263 BACK DISORDER 2 0.0001
264 POST PROCEDURAL INFECTION 1 0.0001
265 METASTASES TO BONE 2 0.0001
266 SKIN DISORDER 4 0.0001
267 CANDIDA INFECTION 2 0.0001
268 INADEQUATE ANALGESIA 1 0.0001
269 MUSCULOSKELETAL DISCOMFORT 2 0.0001
270 PYELONEPHRITIS 1 0.0001
271 ORTHOSTATIC HYPOTENSION 2 0.0001
272 URINE OUTPUT DECREASED 1 0.0001
273 JOINT STIFFNESS 3 0.0001
274 GRIP STRENGTH DECREASED 1 0.0001
275 HAEMARTHROSIS 1 0.0001
276 NERVE COMPRESSION 1 0.0001
277 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
278 HAEMOPTYSIS 3 0.0001
279 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
280 PHOTOPHOBIA 2 0.0001
281 SQUAMOUS CELL CARCINOMA 1 0.0001
282 SPINAL DISORDER 1 0.0001
283 SPUTUM DISCOLOURED 1 0.0001
284 BLOOD URINE PRESENT 2 0.0001
285 RECALLED PRODUCT ADMINISTERED 1 0.0001
286 EYE INFLAMMATION 1 0.0001
287 AFFECT LABILITY 1 0.0001
288 ATELECTASIS 1 0.0001
289 SINUS BRADYCARDIA 1 0.0001
290 ERYTHEMA 21 0.0001
291 NASAL CONGESTION 6 0.0001
292 HEPATOMEGALY 1 0.0001
293 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
294 BLADDER DISORDER 1 0.0001
295 INABILITY TO AFFORD MEDICATION 1 0.0001
296 PRODUCT PHYSICAL ISSUE 2 0.0001
297 HYPOTHERMIA 1 0.0001
298 MOTOR DYSFUNCTION 1 0.0001
299 FEELING HOT 6 0.0001
300 INITIAL INSOMNIA 1 0.0001
301 MOBILITY DECREASED 7 0.0001
302 TENDERNESS 1 0.0001
303 PRODUCT QUALITY ISSUE 13 0.0001
304 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
305 HEAD INJURY 3 0.0001
306 SUDDEN DEATH 1 0.0001
307 JOINT INJURY 2 0.0001
308 DECREASED ACTIVITY 1 0.0001
309 PHARYNGITIS STREPTOCOCCAL 1 0.0001
310 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
311 IMPAIRED HEALING 3 0.0001
312 MUSCULOSKELETAL STIFFNESS 8 0.0001
313 WOUND INFECTION 1 0.0001
314 ASPIRATION 1 0.0001
315 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
316 DENTAL CARIES 1 0.0001
317 STEVENS-JOHNSON SYNDROME 2 0.0001
318 RASH PAPULAR 2 0.0001
319 OCULAR DISCOMFORT 1 0.0001
320 DERMATITIS CONTACT 1 0.0001
321 INTERNAL HAEMORRHAGE 1 0.0001
322 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
323 HYPERSENSITIVITY 16 0.0001
324 PAIN IN EXTREMITY 25 0.0001
325 PERIPHERAL SWELLING 13 0.0001
326 BLOOD IRON DECREASED 1 0.0001
327 MUSCLE RIGIDITY 1 0.0001
328 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
329 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
330 THERAPEUTIC RESPONSE DECREASED 5 0.0001
331 DISCOMFORT 5 0.0001
332 BACK PAIN 19 0.0001
333 MUSCLE SPASTICITY 1 0.0001
334 ABASIA 2 0.0001
335 EYE SWELLING 3 0.0001
336 MUSCLE ATROPHY 1 0.0001
337 ROTATOR CUFF SYNDROME 1 0.0001
338 HIATUS HERNIA 1 0.0001
339 INJECTION SITE INDURATION 1 0.0001
340 NODULE 1 0.0001
341 ARTHRITIS 6 0.0001
342 URINARY TRACT INFECTION 13 0.0001
343 BEDRIDDEN 1 0.0001
344 BLOOD PRESSURE DECREASED 5 0.0001
345 PAIN 46 0.0001
346 SWELLING 7 0.0001
347 PRODUCT TASTE ABNORMAL 1 0.0001
348 UVEITIS 1 0.0001
349 DRUG TOXICITY 1 0.0001
350 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
351 ANAPHYLACTIC REACTION 4 0.0001
352 MASS 1 0.0001
353 WOUND 2 0.0001
354 EYE PAIN 4 0.0001
355 SEASONAL ALLERGY 1 0.0001
356 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
357 LOSS OF CONSCIOUSNESS 9 0.0001
358 INTENTIONAL DOSE OMISSION 2 0.0001
359 RED BLOOD CELL COUNT DECREASED 2 0.0001
360 PARALYSIS 1 0.0001
361 HERPES ZOSTER 4 0.0001
362 PRODUCT USE ISSUE 13 0.0001
363 ANOSMIA 1 0.0001
364 CONSTIPATION 15 0.0001
365 BONE PAIN 4 0.0001
366 BRONCHITIS 5 0.0001
367 URINARY INCONTINENCE 2 0.0001
368 SKIN HAEMORRHAGE 1 0.0001
369 PULMONARY MASS 1 0.0001
370 ECONOMIC PROBLEM 1 0.0001
371 BLOOD COUNT ABNORMAL 1 0.0001
372 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
373 DEVICE FAILURE 1 0.0001
374 DEVICE ADHESION ISSUE 1 0.0001
375 MUSCULOSKELETAL CHEST PAIN 1 0.0001
376 ANKLE FRACTURE 1 0.0001
377 TENDONITIS 1 0.0001
378 CYANOSIS 1 0.0001
379 PRODUCTIVE COUGH 3 0.0001
380 CYSTITIS 2 0.0001
381 GAIT DISTURBANCE 12 0.0001
382 SENSORY DISTURBANCE 1 0.0001
383 MUSCLE TIGHTNESS 1 0.0001
384 AMNESIA 4 0.0001
385 EYE DISORDER 2 0.0001
386 MANIA 1 0.0001
387 HYPOAESTHESIA 9 0.0001
388 ARTHRALGIA 25 0.0001
389 LIP SWELLING 2 0.0001
390 COAGULOPATHY 1 0.0001
391 PERICARDITIS 1 0.0001
392 MYALGIA 10 0.0001
393 CIRCULATORY COLLAPSE 1 0.0001
394 THERAPY CESSATION 3 0.0001
395 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
396 GASTRIC DISORDER 2 0.0001
397 PARANOIA 1 0.0001
398 DEVICE DEFECTIVE 1 0.0001
399 LOCAL SWELLING 1 0.0001
400 RASH MACULAR 2 0.0001
401 INJURY 4 0.0001
402 METASTASES TO LIVER 1 0.0001
403 DEPRESSED MOOD 3 0.0001
404 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
405 HEAD DISCOMFORT 1 0.0001
406 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
407 GALLBLADDER DISORDER 1 0.0001
408 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
409 INFECTION 8 0.0001
410 TOOTHACHE 1 0.0001
411 OSTEOMYELITIS 1 0.0001
412 BONE DISORDER 1 0.0001
413 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
414 MUSCLE SPASMS 10 0.0001
415 MEDICATION ERROR 3 0.0001
416 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
417 FLATULENCE 3 0.0001
418 FOOT FRACTURE 1 0.0001
419 GASTRIC ULCER 1 0.0001
420 MUSCULOSKELETAL DISORDER 1 0.0001
421 POST PROCEDURAL COMPLICATION 1 0.0001
422 LOWER LIMB FRACTURE 1 0.0001
423 CONTUSION 5 0.0001
424 PRESCRIBED OVERDOSE 1 0.0001
425 DYSTONIA 1 0.0001
426 EAR PAIN 1 0.0001
427 DYSPHONIA 3 0.0001
428 PLASMA CELL MYELOMA 2 0.0001
429 CHOKING 1 0.0001
430 KIDNEY INFECTION 1 0.0001
431 DISABILITY 1 0.0001
432 DISORIENTATION 2 0.0001
433 BLOOD PRESSURE ABNORMAL 1 0.0001
434 INJECTION SITE BRUISING 4 0.0001
435 FEEDING DISORDER 1 0.0000
436 TASTE DISORDER 1 0.0000
437 INSOMNIA 13 0.0000
438 RIB FRACTURE 1 0.0000
439 PULMONARY HYPERTENSION 1 0.0000
440 DERMATITIS 1 0.0000
441 KNEE ARTHROPLASTY 1 0.0000
442 HYPOACUSIS 2 0.0000
443 RHINORRHOEA 3 0.0000
444 BALANCE DISORDER 4 0.0000
445 FAECES DISCOLOURED 1 0.0000
446 DEVICE DISLOCATION 2 0.0000
447 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
448 FALL 15 0.0000
449 TOOTH DISORDER 1 0.0000
450 RASH MACULO-PAPULAR 1 0.0000
451 NEOPLASM MALIGNANT 3 0.0000
452 SOMNOLENCE 9 0.0000
453 GLOSSODYNIA 1 0.0000
454 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
455 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
456 THERAPY NON-RESPONDER 2 0.0000
457 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
458 CHROMATURIA 1 0.0000
459 PRURITUS 17 0.0000
460 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
461 PERICARDIAL EFFUSION 1 0.0000
462 RENAL DISORDER 2 0.0000
463 COGNITIVE DISORDER 2 0.0000
464 SLEEP DISORDER 3 0.0000
465 MIGRAINE 4 0.0000
466 RASH ERYTHEMATOUS 2 0.0000
467 MULTIPLE SCLEROSIS 2 0.0000
468 URTICARIA 7 0.0000
469 BLOOD PRESSURE FLUCTUATION 1 0.0000
470 JOINT SWELLING 5 0.0000
471 LOCALISED INFECTION 1 0.0000
472 NEURALGIA 1 0.0000
473 OEDEMA PERIPHERAL 5 0.0000
474 CEREBRAL INFARCTION 1 0.0000
475 DYSGEUSIA 3 0.0000
476 AGEUSIA 1 0.0000
477 DRY EYE 2 0.0000
478 PNEUMONIA ASPIRATION 1 0.0000
479 HOT FLUSH 3 0.0000
480 CELLULITIS 2 0.0000
481 FLUID RETENTION 2 0.0000
482 HYPOPHAGIA 1 0.0000
483 INFLAMMATION 2 0.0000
484 DECREASED APPETITE 9 0.0000
485 ABDOMINAL PAIN 9 0.0000
486 SKIN ULCER 1 0.0000
487 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
488 RESPIRATORY TRACT INFECTION 1 0.0000
489 VOMITING 18 0.0000
490 DEAFNESS 1 0.0000
491 SPEECH DISORDER 2 0.0000
492 DIZZINESS 19 0.0000
493 FEELING ABNORMAL 9 0.0000
494 PRODUCT DOSE OMISSION ISSUE 11 0.0000
495 DIARRHOEA 24 0.0000
496 JAUNDICE 1 0.0000
497 RASH PRURITIC 2 0.0000
498 OEDEMA 2 0.0000
499 LIMB INJURY 1 0.0000
500 VISION BLURRED 5 0.0000
501 MEMORY IMPAIRMENT 5 0.0000
502 DRUG ABUSE 3 0.0000
503 MENTAL STATUS CHANGES 1 0.0000
504 ABDOMINAL DISCOMFORT 6 0.0000
505 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
506 PAIN IN JAW 1 0.0000
507 RHEUMATOID ARTHRITIS 4 0.0000
508 MUSCULAR WEAKNESS 4 0.0000
509 HEADACHE 22 0.0000
510 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
511 HYPERSOMNIA 1 0.0000
512 PRODUCT SUBSTITUTION ISSUE 2 0.0000
513 RASH 15 0.0000
514 COVID-19 6 0.0000
515 SURGERY 2 0.0000
516 ASCITES 1 0.0000
517 PNEUMONIA 11 0.0000
518 DYSPNOEA 19 0.0000
519 DEVICE ISSUE 3 0.0000
520 BLOOD POTASSIUM DECREASED 1 0.0000
521 LACRIMATION INCREASED 1 0.0000
522 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
523 EPILEPSY 1 0.0000
524 GYNAECOMASTIA 1 0.0000
525 SWOLLEN TONGUE 1 0.0000
526 NEUROPATHY PERIPHERAL 3 0.0000
527 MOOD SWINGS 1 0.0000
528 WEIGHT INCREASED 7 0.0000
529 HIP FRACTURE 1 0.0000
530 NIGHT SWEATS 1 0.0000
531 DEEP VEIN THROMBOSIS 2 0.0000
532 PRODUCT DOSE OMISSION 2 0.0000
533 PSORIASIS 4 0.0000
534 VIRAL INFECTION 1 0.0000
535 URINARY RETENTION 1 0.0000
536 GAIT INABILITY 1 0.0000
537 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
538 ANGER 1 0.0000
539 FATIGUE 23 0.0000
540 CHEST DISCOMFORT 3 0.0000
541 NIGHTMARE 1 0.0000
542 MYOCARDIAL INFARCTION 5 0.0000
543 LYMPHADENOPATHY 1 0.0000
544 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
545 NAUSEA 22 0.0000
546 DRUG EFFECT INCOMPLETE 1 0.0000
547 CRYING 1 0.0000
548 PANIC ATTACK 1 0.0000
549 UNDERDOSE 2 0.0000
550 MALAISE 12 0.0000
551 ACCIDENTAL OVERDOSE 1 0.0000
552 DYSURIA 1 0.0000
553 NASOPHARYNGITIS 5 0.0000
554 CHEST PAIN 5 0.0000
555 SEPSIS 3 0.0000
556 EPISTAXIS 2 0.0000
557 DYSPNOEA EXERTIONAL 1 0.0000
558 HALLUCINATION 2 0.0000
559 INTESTINAL OBSTRUCTION 1 0.0000
560 DEPRESSION 6 0.0000
561 CHRONIC KIDNEY DISEASE 2 0.0000
562 SEIZURE 3 0.0000
563 ALOPECIA 5 0.0000
564 ABNORMAL BEHAVIOUR 1 0.0000
565 DRUG INTERACTION 4 0.0000
566 WEIGHT DECREASED 7 0.0000
567 INJECTION SITE HAEMORRHAGE 2 0.0000
568 COUGH 7 0.0000
569 HYPOTENSION 5 0.0000
570 CARDIAC FAILURE CONGESTIVE 2 0.0000
571 THROMBOSIS 2 0.0000
572 EXTRA DOSE ADMINISTERED 1 0.0000
573 DRY MOUTH 2 0.0000
574 PSORIATIC ARTHROPATHY 1 0.0000
575 BLINDNESS 1 0.0000
576 NEUTROPHIL COUNT DECREASED 1 0.0000
577 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
578 TREMOR 4 0.0000
579 RHABDOMYOLYSIS 1 0.0000
580 POLLAKIURIA 1 0.0000
581 CARDIO-RESPIRATORY ARREST 1 0.0000
582 ROAD TRAFFIC ACCIDENT 1 0.0000
583 RENAL IMPAIRMENT 2 0.0000
584 RENAL FAILURE ACUTE 1 0.0000
585 RECTAL HAEMORRHAGE 1 0.0000
586 CONDITION AGGRAVATED 7 0.0000
587 SEPTIC SHOCK 1 0.0000
588 INTENTIONAL PRODUCT MISUSE 2 0.0000
589 ANGIOEDEMA 1 0.0000
590 NEPHROLITHIASIS 1 0.0000
591 ADVERSE EVENT 2 0.0000
592 HYPOKALAEMIA 1 0.0000
593 OROPHARYNGEAL PAIN 2 0.0000
594 CARDIAC DISORDER 2 0.0000
595 ASTHENIA 8 0.0000
596 ARRHYTHMIA 1 0.0000
597 ANXIETY 6 0.0000
598 OCULAR HYPERAEMIA 1 0.0000
599 RENAL CANCER 1 0.0000
600 BLOOD GLUCOSE DECREASED 1 0.0000
601 INTERSTITIAL LUNG DISEASE 1 0.0000
602 ATRIAL FIBRILLATION 2 0.0000
603 LUNG DISORDER 1 0.0000
604 PYREXIA 7 0.0000
605 HEART RATE INCREASED 2 0.0000
606 AGGRESSION 1 0.0000
607 BLOOD PRESSURE INCREASED 3 0.0000
608 SINUSITIS 2 0.0000
609 ILLNESS 2 0.0000
610 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
611 HAEMORRHAGE 2 0.0000
612 PARAESTHESIA 3 0.0000
613 BRADYCARDIA 1 0.0000
614 DRUG DEPENDENCE 3 0.0000
615 DRUG EFFECT DECREASED 1 0.0000
616 CONFUSIONAL STATE 3 0.0000
617 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
618 OFF LABEL USE 16 0.0000
619 HAEMATOCHEZIA 1 0.0000
620 ARTHROPATHY 1 0.0000
621 PANCYTOPENIA 1 0.0000
622 ASTHMA 2 0.0000
623 LETHARGY 1 0.0000
624 PALPITATIONS 2 0.0000
625 BLADDER CANCER 1 0.0000
626 WHEEZING 1 0.0000
627 CATARACT 1 0.0000
628 IRRITABILITY 1 0.0000
629 INJECTION SITE ERYTHEMA 2 0.0000
630 EXPOSURE DURING PREGNANCY 1 0.0000
631 INTENTIONAL OVERDOSE 1 0.0000
632 HYPERHIDROSIS 2 0.0000
633 DEVICE EXPULSION 1 0.0000
634 SWELLING FACE 1 0.0000
635 BLOOD CREATININE INCREASED 1 0.0000
636 DEVICE DIFFICULT TO USE 1 0.0000
637 DEHYDRATION 2 0.0000
638 INJECTION SITE PRURITUS 1 0.0000
639 DEVICE MALFUNCTION 1 0.0000
640 THERAPY INTERRUPTED 1 0.0000
641 AGITATION 1 0.0000
642 UNEVALUABLE EVENT 1 0.0000
643 ACNE 1 0.0000
644 INJECTION SITE PAIN 4 0.0000
645 HOSPITALISATION 2 0.0000
646 CARDIAC FAILURE 1 0.0000
647 PROSTATE CANCER 1 0.0000
648 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
649 DRUG DOSE OMISSION 2 0.0000
650 TOXICITY TO VARIOUS AGENTS 2 0.0000
651 DRUG WITHDRAWAL SYNDROME 1 0.0000
652 TACHYCARDIA 1 0.0000
653 GASTROINTESTINAL DISORDER 1 0.0000
654 ADVERSE DRUG REACTION 1 0.0000
655 SUICIDAL IDEATION 1 0.0000
656 DYSPHAGIA 1 0.0000
657 PULMONARY EMBOLISM 1 0.0000
658 ANAEMIA 2 0.0000
659 DYSPEPSIA 1 0.0000
660 SYNCOPE 1 0.0000
661 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
662 HAEMOGLOBIN DECREASED 1 0.0000
663 ABDOMINAL DISTENSION 1 0.0000
664 PLATELET COUNT DECREASED 1 0.0000
665 THROMBOCYTOPENIA 1 0.0000
666 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
667 CHILLS 1 0.0000
668 DISEASE PROGRESSION 1 0.0000
669 EMOTIONAL DISTRESS 1 0.0000
670 DEATH 7 0.0000
671 VISUAL IMPAIRMENT 1 0.0000
672 RENAL FAILURE 1 0.0000
673 DRY SKIN 1 0.0000
674 BLOOD GLUCOSE INCREASED 1 0.0000
675 ABDOMINAL PAIN UPPER 1 0.0000
676 HYPERTENSION 1 0.0000
677 OVERDOSE 1 0.0000
678 INCORRECT DOSE ADMINISTERED 1 0.0000